IRS 990 Nonprofit Profile
Transpoc INC
Transpoc cultivates open collaboration among a wide range of oncology drug discovery organizations, including academic and medical institutions, emerging drug discovery companies, large biopharmaceutical corporations and disease-based foundations.
Financials
- Filing year
- 2014
- Total revenue
- $-2K
- Total expenses
- $910K
- Total assets
- $81K
- Program expenses
- $618K
- Administration
- $167K
- Fundraising
- $125K
- Program share of expenses
- 68%
- EIN
- 462805281
- Location
- Cambridge, MA
Leadership and Compensation
Leadership is reported as unpaid in the latest filing.
- Stephen Friend - Director
- $0
- Josh Sommer - Director
- $0
- Markus Warmuth - Director, President
- $0
- Yutaka Ishizaka - Secretary
- $0
- Takeshi Hamano - Treasurer
- $0
Officers, directors and key employees with total reported compensation, from Form 990 Part VII.
Governance
- Voting board members
- 3
- Independent members
- 2
Machine-readable CharitySense data
Agents and crawlers can fetch structured JSON for this charity:
About CharitySense
CharitySense provides live, independent intelligence from the charitable infrastructure you fund — hospitals, schools, orphanages, and clinics anywhere in the world.
See live projects or read our insights on nonprofit accountability.
Financial data on this page is sourced from IRS Form 990 filings.